| Tocilizumab is beneficial in moderate to severe RA.(Musculoskeletal Disorders)(rheumatoid arthritis): An article from: Family Practice News | Digitalby Nancy Walsh (Author)
| List Price: | $9.95 | | | Available: | Available for download now |
| | Binding: | Digital | | Publisher: | Thomson Gale | | Page Count: | 3 Pages | | Publication Date: | October 01, 2007 |
|
EDITORIAL REVIEWS |
Product Description
This digital document is an article from Family Practice News, published by Thomson Gale on October 1, 2007. The length of the article is 602 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle: Tocilizumab is beneficial in moderate to severe RA.(Musculoskeletal Disorders)(rheumatoid arthritis)Author: Nancy WalshPublication: Family Practice News (Magazine/Journal)Date: October 1, 2007Publisher: Thomson GaleVolume: 37 Issue: 19 Page: 28(2)Distributed by Thomson Gale |
|
